Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat
- PMID: 2289171
- DOI: 10.1016/0361-9230(90)90180-8
Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat
Abstract
Previous research with hypothalamic injection of serotonin (5-HT) has suggested that this monoamine may act within the medial hypothalamus to suppress carbohydrate intake in a selective, phasic and circadian-related fashion. To explore further the action of 5-HT in the brain, the present studies tested the serotonergic stimulants, d-norfenfluramine (DNF) and d-fenfluramine (DF), in freely feeding, brain-cannulated animals maintained on pure macronutrient diets (protein, carbohydrate and fat) and tested at different times of the diurnal cycle. The results show that administration of DNF into the paraventricular nucleus (PVN) potently influences appetite for a specific nutrient at a particular time of the light-dark cycle. Specifically, DNF injection at the onset of the nocturnal (active) period selectively and dose-dependently suppresses carbohydrate consumption, while leaving protein and fat intake unchanged. This drug, however, has no effect, even at high doses, on macronutrient intake in the middle and late h of the dark phase, strongly implicating a function for hypothalamic 5-HT in the control of carbohydrate ingestion at the beginning of the nocturnal cycle. The possibility that peripherally injected DF may act, in part, through this endogenous serotonergic system is supported by the additional finding that, at low doses of 0.06-0.5 mg/kg, DF preferentially modulates carbohydrate ingestion exclusively at the onset of the nocturnal period. However, at doses above 0.5 mg/kg, this compound produces a potent and general suppression of feeding of all macronutrients. In animals with brain cannulas aimed at different hypothalamic nuclei, the feeding-suppressive effect of DNF is found to be site specific; it is localized to the medial hypothalamic nuclei, including the ventromedial, suprachiasmatic and dorsomedial nuclei as well as the PVN. Serotonin in these nuclei may function to produce satiety specific for carbohydrate and, through the suprachiasmatic nucleus, control energy intake in a circadian-related manner.
Similar articles
-
Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat.Psychopharmacology (Berl). 1991;105(4):467-76. doi: 10.1007/BF02244365. Psychopharmacology (Berl). 1991. PMID: 1771214
-
Effects of serotonin and the serotonin blocker metergoline on meal patterns and macronutrient selection.Pharmacol Biochem Behav. 1993 May;45(1):185-94. doi: 10.1016/0091-3057(93)90103-z. Pharmacol Biochem Behav. 1993. PMID: 8516357
-
Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain.Neuropharmacology. 1991 Feb;30(2):119-23. doi: 10.1016/0028-3908(91)90194-g. Neuropharmacology. 1991. PMID: 2030819
-
Hypothalamic serotonin in control of eating behavior, meal size, and body weight.Biol Psychiatry. 1998 Nov 1;44(9):851-64. doi: 10.1016/s0006-3223(98)00186-3. Biol Psychiatry. 1998. PMID: 9807640 Review.
-
The role of serotonin in eating disorders.Drugs. 1990;39 Suppl 3:33-48. doi: 10.2165/00003495-199000393-00005. Drugs. 1990. PMID: 2197074 Review.
Cited by
-
Obese Animals as Models for Numerous Diseases: Advantages and Applications.Medicina (Kaunas). 2021 Apr 21;57(5):399. doi: 10.3390/medicina57050399. Medicina (Kaunas). 2021. PMID: 33919006 Free PMC article.
-
Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.CNS Drugs. 2003;17(3):167-78. doi: 10.2165/00023210-200317030-00003. CNS Drugs. 2003. PMID: 12617696 Review.
-
Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat.Psychopharmacology (Berl). 1991;105(4):467-76. doi: 10.1007/BF02244365. Psychopharmacology (Berl). 1991. PMID: 1771214
-
Serotonin mediated changes in corticotropin releasing factor mRNA expression and feeding behavior isolated to the hypothalamic paraventricular nuclei.Neurosci Lett. 2011 Jul 12;498(3):213-7. doi: 10.1016/j.neulet.2011.05.011. Epub 2011 May 11. Neurosci Lett. 2011. PMID: 21600959 Free PMC article.
-
Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.J Neurosci. 1998 Jul 15;18(14):5537-44. doi: 10.1523/JNEUROSCI.18-14-05537.1998. J Neurosci. 1998. PMID: 9651234 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous